Company
VTR +1.73%Ventas
Market Cap: $45.46 Billion
USD as of Aug 2, 2026
$VTR +1.73% $VTR United States Real Estate REIT—Healthcare Facilities US Real Estate US REIT—Healthcare FacilitiesCompany Description
Ventas, Inc. owns, manages, and invests in healthcare and senior housing real estate, including senior living, outpatient medical, life science, hospital, and skilled nursing properties.
Ventas Market Capitalization Over Time
View HistoryEvolution of Ventas, Inc. market cap in the past 5 years
Market capitalizations are calculated from the opening stock price at the beginning of each month.
Top Competitors by Market Capitalization
Industry: REIT—Healthcare Facilities
Sector: Real Estate
| Company | Market Cap (USD) |
|---|---|
| Welltower | $168.93 B |
| Prologis | $137.97 B |
| Equinix | $100.53 B |
| Simon Property Group | $87.16 B |
| American Tower | $80.78 B |
Detailed Description
Ventas Inc. is a real estate investment trust that focuses on owning, managing, and investing in healthcare and senior housing properties. The company’s portfolio spans senior living communities, outpatient medical facilities, life science and research centers, hospitals, and skilled nursing and post-acute care properties across the United States, Canada, and the United Kingdom. Ventas operates through distinct business segments, including senior housing operating assets, outpatient medical and research properties, and triple-net leased properties, allowing it to partner closely with operators, healthcare providers, and research institutions. By concentrating on real estate that supports healthcare delivery and aging populations, Ventas plays a central role in the medical and senior living infrastructure. The company also holds a small portion of its assets in mortgages and other loans secured by healthcare properties. Founded in 1983 and headquartered in Chicago, Illinois, Ventas is recognized as a leading participant in the global healthcare real estate market.
Financials
| Last Financial Reports Date | March 31, 2026 |
| Revenue TTM | $6.11 B |
| EBITDA | $2.30 B |
| Gross Profit TTM | $2.48 B |
| Profit Margin | 4.26% |
| Operating Margin | 13.77% |
| Quarterly Revenue Growth | 21.90% |
Stocks & Indexes
Ventas, Inc. main stocks and indexes inclusions.
$VTRRussell 1000 Russell 3000 S&P 500
Product & Services
Health care establishments
Key People
CEO: Ms. Debra A. Cafaro J.D.
Employees: 542